Market Cap 580.14B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 22.28
Forward PE 20.67
Profit Margin 28.46%
Debt to Equity Ratio 0.46
Volume 10,134,500
Avg Vol 8,112,154
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 84%
Beta 0.26
Analysts Strong Sell
Price Target $260.46

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
BarkingPuppy
BarkingPuppy Jun. 26 at 2:15 PM
0 · Reply
Jamtrades
Jamtrades Jun. 26 at 2:11 PM
Dormant shorts are getting lit up in Pharma names. They are screwed .. $JNJ and $LLY squeeze continues violently as investors seek alpha on this rebalancing day $DIA $SPY
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 2:10 PM
$ELTP $WEN $PFE $JNJ Big News coming next Week, Earning Monday......... Elite Pharmaceuticals (stock ticker: ELTP) stands out as a remarkable stock with strong fundamentals and promising potential. Recently trading around $0.38 to $0.40, ELTP has shown positive momentum with gains over 1.5% to 5% in recent sessions. The company boasts a solid market capitalization near $400 million and a reasonable price-to-earnings ratio around 10, indicating good value relative to earnings. Despite some recent stock fluctuations, ELTP has demonstrated solid quarterly earnings and revenue performance, underscoring its operational strength. For investors looking for a promising pharmaceutical stock with growth potential and solid financials, ELTP is definitely worth attention.
0 · Reply
vanguard100
vanguard100 Jun. 26 at 2:08 PM
$JNJ 0DTE calls up over 300%..
0 · Reply
E458
E458 Jun. 26 at 2:03 PM
$SPY when the market should be falling but isnt its always these heroes: $JNJ $LLY and then some random tech giant like $MSFT or $AAPL
0 · Reply
frb1985
frb1985 Jun. 26 at 1:56 PM
$JNJ wait what is that a new high. LOL
0 · Reply
vanguard100
vanguard100 Jun. 26 at 1:49 PM
$JNJ Looks good for some intra day upside...on watch ..
0 · Reply
Jamtrades
Jamtrades Jun. 26 at 1:48 PM
Investors are rotating into defensive names; $LLY and $JNJ
0 · Reply
GettnFibbywIT
GettnFibbywIT Jun. 26 at 1:46 PM
0 · Reply
yellowstar16
yellowstar16 Jun. 26 at 1:42 PM
$JNJ 52 week high.
0 · Reply
Latest News on JNJ
Johnson & Johnson presents first results from ENERGY study

2026-06-11T09:26:54.000Z - 15 days ago

Johnson & Johnson presents first results from ENERGY study

JNJ


Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 9:01 AM EDT - 18 days ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion

JNJ


Johnson & Johnson to acquire Firefly Bio for $1B in cash

2026-06-08T12:14:56.000Z - 18 days ago

Johnson & Johnson to acquire Firefly Bio for $1B in cash

JNJ


Johnson & Johnson to buy Firefly Bio for $1 billion

Jun 8, 2026, 8:08 AM EDT - 18 days ago

Johnson & Johnson to buy Firefly Bio for $1 billion

JNJ


Johnson & Johnson says nipocalimab approved in China

May 21, 2026, 4:31 AM EDT - 5 weeks ago

Johnson & Johnson says nipocalimab approved in China

JNJ


CVS to drop J&J's Stelara from its main formularies

May 5, 2026, 9:15 AM EDT - 7 weeks ago

CVS to drop J&J's Stelara from its main formularies

CVS JNJ


Why These 3 Forever Stocks Belong on Your Watchlist

Apr 28, 2026, 11:10 AM EDT - 2 months ago

Why These 3 Forever Stocks Belong on Your Watchlist

JNJ WMT XOM


J&J sees AI halving the time to generate drug development leads

Apr 27, 2026, 11:03 AM EDT - 2 months ago

J&J sees AI halving the time to generate drug development leads

JNJ


Johnson & Johnson Transcript: AGM 2026

Apr 23, 2026, 10:00 AM EDT - 2 months ago

Johnson & Johnson Transcript: AGM 2026


BarkingPuppy
BarkingPuppy Jun. 26 at 2:15 PM
0 · Reply
Jamtrades
Jamtrades Jun. 26 at 2:11 PM
Dormant shorts are getting lit up in Pharma names. They are screwed .. $JNJ and $LLY squeeze continues violently as investors seek alpha on this rebalancing day $DIA $SPY
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 2:10 PM
$ELTP $WEN $PFE $JNJ Big News coming next Week, Earning Monday......... Elite Pharmaceuticals (stock ticker: ELTP) stands out as a remarkable stock with strong fundamentals and promising potential. Recently trading around $0.38 to $0.40, ELTP has shown positive momentum with gains over 1.5% to 5% in recent sessions. The company boasts a solid market capitalization near $400 million and a reasonable price-to-earnings ratio around 10, indicating good value relative to earnings. Despite some recent stock fluctuations, ELTP has demonstrated solid quarterly earnings and revenue performance, underscoring its operational strength. For investors looking for a promising pharmaceutical stock with growth potential and solid financials, ELTP is definitely worth attention.
0 · Reply
vanguard100
vanguard100 Jun. 26 at 2:08 PM
$JNJ 0DTE calls up over 300%..
0 · Reply
E458
E458 Jun. 26 at 2:03 PM
$SPY when the market should be falling but isnt its always these heroes: $JNJ $LLY and then some random tech giant like $MSFT or $AAPL
0 · Reply
frb1985
frb1985 Jun. 26 at 1:56 PM
$JNJ wait what is that a new high. LOL
0 · Reply
vanguard100
vanguard100 Jun. 26 at 1:49 PM
$JNJ Looks good for some intra day upside...on watch ..
0 · Reply
Jamtrades
Jamtrades Jun. 26 at 1:48 PM
Investors are rotating into defensive names; $LLY and $JNJ
0 · Reply
GettnFibbywIT
GettnFibbywIT Jun. 26 at 1:46 PM
0 · Reply
yellowstar16
yellowstar16 Jun. 26 at 1:42 PM
$JNJ 52 week high.
0 · Reply
GettnFibbywIT
GettnFibbywIT Jun. 26 at 1:42 PM
$JNJ $XLV Johnson & Johnson (JNJ) vs Healthcare Sector (XLV) Weekly Relative Strength The JNJ/XLV ratio is stabilizing at a confluence zone defined by repeated horizontal structural interaction and a Fibonacci retracement level, with recent price behavior indicating a loss of seller control and early signs of demand re-emerging. Momentum is beginning to improve - although confirmation of sustained relative strength will require further structural acceptance and continued RSI progression:
0 · Reply
Jamtrades
Jamtrades Jun. 26 at 1:36 PM
$JNJ is a structural winner! Runs into earnings on defensive rotation
0 · Reply
dewmoore
dewmoore Jun. 26 at 12:16 PM
The Morning Dip & The 9:30 Rip This week $SLS slides early only to explode at the opening bell Here is the exact daily blueprint of how $SLS trading flows right now: Premarket (4AM – 9:30 AM) The Action:Thin, low-volume trading (avg. **150k–250k shares**). Shorts+algos easily push the price down on zero news, hunting for retail stop-losses. The Opening Bell (9:30 AM – 11:30 AM) Retail volume floods the gates (2.5M–4M shares in 2 hours). Trapped shorts face massive triple-digit borrow fees, sparking immediate upward rips and aggressive reversals. Midday Lull (11:30 AM – 2PM) Volume drops -The stock builds a higher base and flags out while the broader biotech market adjusts. Power Hour (2PM – 4 PM) Late day momentum returns. Traders aggressively position overnight to protect against an off-hours REGAL 80th event data drop or a buyout announcement. The trend is turning heavily bullish. We've ground up from Monday's $8.30S and shattered double digits. GLTA $SLS 🚀 $LLY $JNJ
0 · Reply
TalkMarkets
TalkMarkets Jun. 26 at 8:22 AM
Dividend Stock Analysis: Johnson & Johnson (JNJ) $JNJ $ABBV $LLY $BMY https://talkmarkets.com/article/dividend-stock-analysis-johnson-johnson-jnj-1782462113
0 · Reply
TraderDaKing
TraderDaKing Jun. 25 at 7:27 PM
$ELTP $PFE $JNJ $WEN News breaking............ Here we go !!! Some knows something...... Hold the Line. No Selling Wait until Next Week..... Earning are Monday...... and a major call is Tuesday.....
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 25 at 7:25 PM
$ELTP $JNJ $PFE Look At this..... Big buying trying to get in....
0 · Reply
PittsburghTrader
PittsburghTrader Jun. 25 at 6:37 PM
$SMH kind of crazy signal that most risk on down today yet $SMH holding a bid while risk off trades like $JNJ & $MRK are also up strongly
0 · Reply
LevelsOwl
LevelsOwl Jun. 25 at 3:41 PM
$JNJ today: Buyers are stepping in while price remains above both the 50-day and 200-day moving averages, keeping the broader uptrend intact as long as $244 holds. What confirms strength: A stable hold above VWAP into the close signals continued demand and keeps pressure toward the $250$252 zone. What weakens it: A clean break below $244 would open the door for a pullback toward the $241 area where momentum may cool. Simple read: The trend remains constructive while price stays above key intraday support. Quick takeaway: Holding above $245 keeps the setup biased toward another push toward recent highs. Overall price action is stable and slightly under prior peaks, with upside continuation still possible if support holds.
0 · Reply
Estimize
Estimize Jun. 25 at 2:12 PM
Wall St is expecting 2.85 EPS for $JNJ Q2 [Reporting 07/15 BMO] http://www.estimize.com/intro/jnj?chart=historical&metric_name=eps&utm_cont
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Jun. 25 at 1:52 PM
$JNJ $LLY $MRK $PFE $SLS Pfizer needs this victory ✌️ NOW! ✌️🙏❤️‍🩹
0 · Reply
GettnFibbywIT
GettnFibbywIT Jun. 25 at 1:49 PM
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Jun. 25 at 1:49 PM
$JNJ $LLY $MRK $PFE $SLS Pfizer it is. ✌️🙏❤️‍🩹
0 · Reply